Efficacies of Lipophilic Inhibitors of Dihydrofolate Reductase against Parasitic Protozoa
Open Access
- 1 January 2001
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (1) , 187-195
- https://doi.org/10.1128/aac.45.1.187-195.2001
Abstract
Competitive inhibitors of dihydrofolate reductase (DHFR) are used in chemotherapy or prophylaxis of many microbial pathogens, including the eukaryotic parasites Plasmodium falciparum and Toxoplasma gondii . Unfortunately, point mutations in the DHFR gene can confer resistance to inhibitors specific to these pathogens. We have developed a rapid system for testing inhibitors of DHFRs from a variety of parasites. We replaced the DHFR gene from the budding yeast Saccharomyces cerevisiae with the DHFR-coding region from humans, P. falciparum , T. gondii , Pneumocystis carinii , and bovine or human-derived Cryptosporidium parvum . We studied 84 dicyclic and tricyclic 2,4-diaminopyrimidine derivatives in this heterologous system and identified those most effective against the DHFR enzymes from each of the pathogens. Among these compounds, six tetrahydroquinazolines were effective inhibitors of every strain tested, but they also inhibited the human DHFR and were not selective for the parasites. However, two quinazolines and four tetrahydroquinazolines were both potent and selective inhibitors of the P. falciparum DHFR. These compounds show promise for development as antimalarial drugs.Keywords
This publication has 45 references indexed in Scilit:
- One-step synthesis of novel 2,4-diaminopyrimidine antifolates from bridged alicyclic ketones and cyanoguanidineJournal of Heterocyclic Chemistry, 1999
- 2,4-Diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine Analogues of Trimethoprim as Inhibitors of Pneumocystis carinii and Toxoplasma gondii Dihydrofolate ReductaseJournal of Medicinal Chemistry, 1998
- 2,4-Diaminothieno[2,3-d]pyrimidine Lipophilic Antifolates as Inhibitors of Pneumocystis carinii and Toxoplasma gondii Dihydrofolate ReductaseJournal of Medicinal Chemistry, 1997
- Brominated trimetrexate analogues as inhibitors of pneumocystis carinii and toxoplasma gondii dihydrofolate reductaseJournal of Heterocyclic Chemistry, 1996
- 2,4-Diamino-5-substituted-quinazolines as Inhibitors of a Human Dihydrofolate Reductase with a Site-Directed Mutation at Position 22 and of the Dihydrofolate Reductases from Pneumocystis carinii and Toxoplasma gondiiJournal of Medicinal Chemistry, 1995
- The phenotype of a dihydrofolate reductase mutant of Saccharomyces cerevisiaeGene, 1992
- Methotrexate analogs. 8. Synthesis and biological evaluation of bisamide derivatives as potential prodrugsJournal of Medicinal Chemistry, 1977
- Methotrexate analogs. 6. Replacement of glutamic acid by various amino acid esters and aminesJournal of Medicinal Chemistry, 1975
- Methotrexate analogs. 3. Synthesis and biological properties of some side-chain altered analogsJournal of Medicinal Chemistry, 1974
- Analogs of Pteroylglutamic Acid. III. 4-Amino DerivativesJournal of the American Chemical Society, 1949